All Stories

  1. General guidelines for biomedical software development
  2. Identifiers for the 21st century: How to design, provision, and reuse persistent identifiers to maximize utility and impact of life science data
  3. Bridging the translational innovation gap through good biomarker practice
  4. Identifiers for the 21st century: How to design, provision, and reuse persistent identifiers to maximize utility and impact of life science data
  5. General guidelines for biomedical software development
  6. Identifying ELIXIR Core Data Resources
  7. Data management: A global coalition to sustain core data
  8. TOWARDS COORDINATED INTERNATIONAL SUPPORT OF CORE DATA RESOURCES FOR THE LIFE SCIENCES
  9. Erratum to: Making sense of big data in health research: towards an EU action plan
  10. Identifying ELIXIR Core Data Resources
  11. Making sense of big data in health research: Towards an EU action plan
  12. The ELIXIR channel in F1000Research
  13. The FAIR Guiding Principles for scientific data management and stewardship
  14. Patterns of database citation
  15. The ELIXIR channel in F1000Research
  16. A Quick Guide for Building a Successful Bioinformatics Community
  17. CHAPTER 13. Bioinformatics for Medicinal Chemistry
  18. Mining Molecular Pharmacological Effects from Biomedical Text: a Case Study for Eliciting Anti-Obesity/Diabetes Effects of Chemical Compounds
  19. The Scientific Requirements for Integrating chemistry and biology data on the Open PHACTS platform
  20. Big pharma screening collections: more of the same or unique libraries? The AstraZeneca–Bayer Pharma AG case
  21. Scientific competency questions as the basis for semantically enriched open pharmacological space
  22. An outline of what Open PHACTS is
  23. Theoretical Studies of Chemical Reactivity of Metabolically Activated Forms of Aromatic Amines toward DNA
  24. SARConnect: A Tool to Interrogate the Connectivity Between Proteins, Chemical Structures and Activity Data
  25. Taking Open Innovation to the Molecular Level - Strengths and Limitations
  26. A comparative analysis of the molecular topologies for drugs, clinical candidates, natural products, human metabolites and general bioactive compounds
  27. Strategies to improve in vivo toxicology outcomes for basic candidate drug molecules
  28. Design and synthesis of macrocyclic indoles targeting blood coagulation cascade Factor XIa
  29. Combinatorial Library Design from Reagent Pharmacophore Fingerprints
  30. Physicochemical property profiles of marketed drugs, clinical candidates and bioactive compounds
  31. Comparative binding energy analysis for binding affinity and target selectivity prediction
  32. Designing a Combinatorial Library by Using Reagent Pharmacophore Fingerprint
  33. ProSAR: A New Methodology for Combinatorial Library Design
  34. Design of compound libraries for fragment screening
  35. An Integrated Approach to Fragment-Based Lead Generation:Philosophy, Strategy and Case Studies from AstraZenecas Drug Discovery Programmes
  36. Structure-based organic synthesis of unnatural aeruginosin hybrids as potent inhibitors of thrombin
  37. Development, interpretation and temporal evaluation of a global QSAR of hERG electrophysiology screening data
  38. Total Synthesis and Structural Confirmation of Chlorodysinosin A.
  39. Total Synthesis and Structural Confirmation of Chlorodysinosin A  [ J. Am. Chem. Soc. 2006 , 128 , 10491−10495]. 
  40. Total Synthesis and Structural Confirmation of Chlorodysinosin A
  41. Multifingerprint Based Similarity Searches for Targeted Class Compound Selection.
  42. Multifingerprint Based Similarity Searches for Targeted Class Compound Selection
  43. Structure of the PPARα and -γ Ligand Binding Domain in Complex with AZ 242; Ligand Selectivity and Agonist Activation in the PPAR Family
  44. Structure of a PH Domain from the C. elegans Muscle Protein UNC-89 Suggests a Novel Function
  45. Classification of protein sequences by homology modeling and quantitative analysis of electrostatic similarity
  46. The PH superfold: a structural scaffold for multiple functions
  47. Functional diversity of PH domains: an exhaustive modelling study
  48. Internal repeats in the BRCA2 protein sequence